title: Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity.
abstract: Individuals suffering from type 2 diabetes or obesity exhibit a significant increase in the incidence of various types of cancer. It is generally accepted that those conditions arise from overnutrition and a sedentary lifestyle, which lead to insulin resistance characterized by overproduction of insulin acting as a growth factor. There is a consensus based largely on epidemiological data that chronic overproduction of insulin is responsible for the increased incidence of cancer. A model system in culture of NIH 3T3 cells induces the collective effects of serum growth factors on progression through the stages of field cancerization. It shows that the driving force of progression is promotion of cell growth under selection at high cell density, with no requirement for exogenous carcinogenic agents. The early effect is gradual selection among many preexisting, low-penetrance preneoplastic mutations or stable epigenetic variants, followed by sporadic, high-penetrance transforming variants, all dependent on endogenous processes. The significance of the results for cancer in diabetic and obese individuals is that the initial stages of the process involve multiorgan metabolic interactions that produce a systemic insulin resistance with chronic overproduction of insulin and localized field cancerization. Hypomagnesemia is prevalent in the foregoing metabalo/systemic disorders, and may also provide a selective microenvironment for tumor development.
authors.affiliation: Department of Molecular and Cell Biology, Life Sciences Addition, University of California, Berkeley, CA 94720-3200, USA. hrubin@berkeley.edu
authors.forename: Harry
authors.initials: H
authors.lastname: Rubin
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006946:Hyperinsulinism / Q000150:complications* / Q000209:etiology; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood* / Q000494:pharmacology; D051379:Mice; D008954:Models, Biological; D041681:NIH 3T3 Cells; D009369:Neoplasms / Q000209:etiology*; D009765:Obesity / Q000150:complications*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins
keywords: hyperinsulinemia; neoplastic transformation; preneoplasia
references.citation: Diabetes Care. 2005 May;28(5):1175-81
references.pmid: 15855585
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1271-9
references.pmid: 11142411
references.citation: Science. 2011 Mar 25;331(6024):1553-8
references.pmid: 21436442
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(24):10005-9
references.pmid: 2263601
references.citation: Proc Natl Acad Sci U S A. 1989 Mar;86(6):1860-4
references.pmid: 2928308
references.citation: J Cell Physiol. 1977 May;91(2):249-59
references.pmid: 558985
references.citation: Virology. 1958 Dec;6(3):669-88
references.pmid: 13616179
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9276-81
references.pmid: 15967983
references.citation: In Vitro. 1981 Aug;17(8):656-70
references.pmid: 7327595
references.citation: Proc Natl Acad Sci U S A. 2012 May 22;109(21):8236-40
references.pmid: 22547801
references.citation: Proc Natl Acad Sci U S A. 1968 May;60(1):300-4
references.pmid: 5241531
references.citation: Cancer Res. 1987 Sep 15;47(18):4924-31
references.pmid: 3621184
references.citation: Cancer Res. 2008 Jan 1;68(1):329-37
references.pmid: 18172327
references.citation: Am J Hypertens. 1999 Aug;12(8 Pt 1):747-56
references.pmid: 10480466
references.citation: Nature. 2010 Sep 30;467(7315):587-90
references.pmid: 20844486
references.citation: Oncogene. 2004 Oct 18;23(48):7910-7
references.pmid: 15489909
references.citation: Science. 2002 Apr 26;296(5568):695-8
references.pmid: 11976443
references.citation: Bioessays. 2011 Mar;33(3):224-31
references.pmid: 21254148
references.citation: J Clin Endocrinol Metab. 1995 Apr;80(4):1382-5
references.pmid: 7714114
references.citation: Annu Rev Genet. 1984;18:553-612
references.pmid: 6397126
references.citation: Science. 2002 Apr 26;296(5568):686-9
references.pmid: 11976439
references.citation: J Nutr. 2013 Mar;143(3):345-53
references.pmid: 23343670
references.citation: Endocrinology. 2006 Apr;147(4):1830-7
references.pmid: 16410309
references.citation: Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):1013-5
references.pmid: 8959325
references.citation: J Cell Sci. 1988 Dec;91 ( Pt 4):571-6
references.pmid: 3255757
references.citation: Am J Hypertens. 1997 Mar;10(3):346-55
references.pmid: 9056694
references.citation: Cancer Res. 1984 Oct;44(10):4217-23
references.pmid: 6467183
references.citation: J Clin Oncol. 2009 Jan 10;27(2):165-7
references.pmid: 19064959
references.citation: J Natl Cancer Inst. 1997 Sep 17;89(18):1360-5
references.pmid: 9308706
references.citation: J Am Coll Nutr. 2006 Jun;25(3):210-5
references.pmid: 16766779
references.citation: Nat Rev Cancer. 2004 Aug;4(8):579-91
references.pmid: 15286738
references.citation: Cancer Res. 1996 Jun 1;56(11):2488-92
references.pmid: 8653682
references.citation: Magnes Res. 2004 Jun;17(2):126-36
references.pmid: 15319146
references.citation: Proc Natl Acad Sci U S A. 1990 Jan;87(1):482-6
references.pmid: 2296603
references.citation: J Nutr. 2001 Nov;131(11 Suppl):3109S-20S
references.pmid: 11694656
references.citation: Br J Cancer. 2012 Jan 3;106(1):227-32
references.pmid: 22127286
references.citation: Science. 2012 Jan 6;335(6064):28, 30-2
references.pmid: 22223787
references.citation: Hum Mutat. 1995;5(1):48-57
references.pmid: 7728149
references.citation: Science. 2003 May 16;300(5622):1140-2
references.pmid: 12750520
references.citation: Cancer. 1953 Sep;6(5):963-8
references.pmid: 13094644
references.citation: Science. 2013 Jan 11;339(6116):172-7
references.pmid: 23307735
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):47-56
references.pmid: 12540503
references.citation: J Cell Physiol. 1968 Oct;72(2):141-8
references.pmid: 4301006
references.citation: Nat Rev Cancer. 2011 Nov 24;11(12):886-95
references.pmid: 22113164
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12244-9
references.pmid: 11035769
references.citation: J Cell Physiol. 1976 Dec;89(4):613-25
references.pmid: 1034633
references.citation: J Cell Physiol. 1978 Sep;96(3):265-78
references.pmid: 670310
references.citation: Cancer Res. 2010 Sep 1;70(17):6797-803
references.pmid: 20656803
references.citation: Cancer Res. 1991 Feb 1;51(3):1003-13
references.pmid: 1988112
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6215-21
references.pmid: 18434545
references.citation: Cancer Res. 2003 Apr 15;63(8):1727-30
references.pmid: 12702551